Neutrophilic dermatosis associated with propylthiouracil-induced p-ANCA (p-antineutrophil cytoplasmic antibodies);Dermatose neutrophilique associée à des anticorps anticytoplasme des polynucléaires neutrophiles (p-ANCA) induits par le propylthiouracil

Annales de Dermatologie et de Venereologie

Volumn 132, Issue 1, 2005, Pages 27-31

  Boulenger Vazel, A ^a   Kupfer Bessaguet, I ^a   Gouedard, C ^a   Leberre, R ^a   Leroy, J P ^a   Sonnet, E ^a   Desvignes, O ^a   Misery, L ^a   Sassolas, B ^a,b  

^a BREST UNIVERSITY HOSPITAL   (France)

^b CHU MORVAN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; NEUTROPHIL CYTOPLASMIC ANTIBODY; PROPYLTHIOURACIL;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; ERYTHEMA; FEMALE; GAMMOPATHY; GRAVES DISEASE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERTHYROIDISM; IMMUNOFLUORESCENCE TEST; NEUTROPHIL CHEMOTAXIS; PUSTULE; PYODERMA GANGRENOSUM; SKIN BIOPSY; SUBCORNEAL PUSTULAR DERMATOSIS; TREATMENT FAILURE; TRUNK;

EID: 14044253487     PISSN: 01519638     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0151-9638(05)79191-2     Document Type: Article

References (25)

1. Romani J, Puig L, de Moragas JM. Detection of antineutrophil cytoplasmic antibodies in patients with hepatitis C virus-induced cutaneous vasculitis with mixed cryoglobulinemia. Arch Dermatol 1996;132:974-5.
2. Burrows NP, Lockwood CM. Antineutrophil cytoplasmic antibodies and their relevance to the dermatologist. Br J Dermatol 1995;132:173-81.
3. Dolman KM, Gans ROB, Vervaat THJ, Zevenbergen G, Maingay Dick, Nikkels RM et al. Vasculitis and antineutrophil cytoplasmic autoantibodies associated with propylthiouracil therapy. Lancet 1993;342:651-2.
4. Darben T, Savige J, Prentice R, Paspaliaris B, Chick J. Pyoderma gangrenosum with secondary pyoarthrosis following propylthiouracil. Australas J Dermatol 1999;40:144-6.
5. Elkayam O, Yaron M, Caspi D. Minocycline-induced autoimmune syndromes: an overview. Semin Arthritis Rheum 1999;28:392-7.
6. Merkel PA. Drugs associated with vasculitis. Curr Opin Rheumatol 1998;10:45-50.
7. Sera N, Ashizawa K, Ando T, Abe Y, Ide A, Usa T et al. Treatment with PTU is associated with appearance of antineutrophil cytoplasmic antibodies in some patients with Graves'disease. Thyroid 2000;10:595-9.
8. Miller RM, Darben TA, Nedwich J, Savige J. Propyltiouracil-induced antineutrophil cytoplasmic antibodies in a patient with Graves'disease and a neutrophilic dermatosis. Br J Dermatol 1999;141:943-4.
9. Noh JY, Asari T, Hamada N, Makino F, Ishikawa N, Abe Y et al. Frequency of appearance of myeloperoxydase-antineutrophil cytoplasmic antibody (MPO-ANCA) in Graves'disease patients treated with propylthiouracil and the relationship between MPO-ANCA and clinical manifestations. Clin Endocrinol 2001;54:651-4.
10. Sato H, Hattori M, Fujieda M, Sugihara S, Inomata H, Hoshi M, Miyamoto S. High prevalence of antineutrophil cytoplasmic antibody positivity in childhood onset Graves'disease treated with propylthiouracil. J Clin Endocrinol Metab 2000;85:4270-3.
11. Noh JY, Asari T, Hamada N, Makino F, Ishikawa N, Abe Y et al. Frequency of appearance of myeloperoxydase-antineutropil cytoplasmic antibody (MPO-ANCA) in Graves'disease patients treated with propylthiouracil and the relationship between MPO-ANCA and clinical manifestations. Clin Endocrinol (Oxf) 2002;57:699-700.
12. Wada N, Mukai M, Kohno M, Notoya A, Ito T, Yoshioka N. Prevalence of serum anti-myeloperoxidase antineutrophil cytoplasmic antibodies (MPO-ANCA) in patients with Grave disease treated with propylthiouracil and thiamazole. Endocrinol J 2002;49:329-34.
13. Guton JE, Stiel J, Caterson RJ, McElduff A. Anti-thyroid drugs and antineutrophil cytoplasmic antibody positive vasculitis. A case report and review of the literature. J Clin Endocrinol Metab 1999;84:13-6.
14. Morita S, Ueda Y, Eguchi K. Anti-thyroid drug-induced ANCA-associated vasculitis: a case report and review of the literature. Endocr J 2000;7:467-70.
15. Ohya N, Suzuki Y, Ichikawa Y, Ito K. Relapsing polychondritis developing in a patient with Grave disease: a possible association with propylthiouracil. Nihon Rinsho Meneki Gakkai Kaishi 1999;22:30-6.
16. Thong HY, Chu CY, Chiu HC. Methimazole-induced antineutrophil cytoplasmic antibody (ANCA)- associated vasculitis and lupus-like syndrome with a cutaneous feature of vesiculo-bullous systemic lupus erythematosus. Acta Derm Venereol 2002;82:206-8.
17. Nakamura S, Nakayama K, Imai T, Idhara C, Ootani A. Sweet's syndrome in a patient with Basedow's disease. J Dermatol 1988;15:451-3.
18. Burrows NP. Anti-neutrophil cytoplasmic antibodies in Sweet's syndrome. J Am Acad Dermatol 1994;31:825-6.
19. Rovel-Guitera P, Diemert MC, Charuel JL, Laporte JL, Musset L, Chosidow O et al. IgA antineutrophil cytoplasmic antibodies in cutaneous vasculitis. Br J Dermatol 2000;143:99-103.
20. Von den Driesch P, Weber MF. Are antibodies to neutrophilic cytoplasmic antigens (ANCA) a serologic marker for Sweet's syndrome? J Am Acad Dermatol 1993;29:666.
21. Bayle P, Laplanche C, Gorgeuet B, Oksman F, Boulinguez S, Bazex J. Neutrophilic dermatosis: a case of overlapping syndrome with monoclonal antineutrophil cytoplasmic autoantibody activity. Dermatology 1994;189:69-71.
22. Hoffman MD. Pyoderma gangrenosum associated with c-ANCA (H-lamp). Int J Dermatol 2001;40:135-7.
23. Taniguchi S, Tsuruta D, Kutsuna H, Hamada T. Subcorneal pustular dermatosis in a patient with hyperthyroidism. Dermatology 1995;190:4-6.
24. Lam DCC, Lindsay RH. Accumulation of 2- (14C) propylthiouracil in human polymorphonuclear leukocytes. Biochem Pharmacol 1979;28:289-96.
25. Lee H, Hirouchi M, Hosokawa M, Sayo H, Kohno M, Kariya K. Inactivation of peroxydase of rate bone marrow by repeated administration of propylthiouracil is accompanied by change in the heme structure. Biochem Pharmacol 1988;37:2151-3.